Renaissance Technologies - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$274
-31.7%
36,000
-41.1%
0.00%
-100.0%
Q2 2023$401
+162.1%
61,114
+138.7%
0.00%
Q1 2023$153
+75.9%
25,600
-31.2%
0.00%
Q4 2022$87
-99.9%
37,200
-13.5%
0.00%
Q3 2022$144,000
+136.1%
43,000
+87.0%
0.00%
Q2 2022$61,00023,0000.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 2,409,220$8,071,0009.37%
Abingworth LLP 2,073,957$6,948,0002.38%
Aisling Capital Management LP 886,075$2,968,0001.97%
NEA Management Company, LLC 4,786,921$16,036,0000.80%
Novo Holdings A/S 3,430,377$11,492,0000.55%
Ikarian Capital, LLC 155,819$521,0000.10%
Rock Springs Capital Management LP 1,143,185$3,830,0000.10%
Ergoteles LLC 37,640$126,0000.00%
MAI Capital Management 63,210$212,0000.00%
RBF Capital, LLC 14,536$49,0000.00%
View complete list of RENEO PHARMACEUTICALS INC shareholders